Hinneburg Iris
Med Monatsschr Pharm. 2017 Apr;40(4):175-7.
Compared to randomized controlled trials, non-randomized studies of interventions might be biased in additional domains. As most previous tools for assessing risk of bias are not sufficient, a Cochrane working group has developed a new risk of bias tool called ROBINS-I (Risk of bias in non-randomized studies of interventions).
与随机对照试验相比,干预措施的非随机研究可能在其他方面存在偏倚。由于以往大多数评估偏倚风险的工具都不够充分,一个Cochrane工作组开发了一种名为ROBINS-I(干预措施非随机研究中的偏倚风险)的新偏倚风险工具。